Open Insider Trading Activity for Intra-Cellular Therapies, Inc. EVP, Chief Commercial Officer Neumann Mark
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. ITCI | 2024-08-20 | 2024-08-16 | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Sell | 1 | 18,714 | $75.08 | $1,405,047.12 | 38.65% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ITCI | 2024-03-11 | 2024-03-11 | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Sell | 5 | 20,477 | $66.23 | $1,356,109.71 | 11.52% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ITCI | 2024-02-27 | 2024-02-26 | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Sell | 4 | 7,907 | $70.13 | $554,491.00 | 5.67% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ITCI | 2024-02-05 | 2024-02-02 | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | Sell | 2 | 11,860 | $67.15 | $796,367.48 | 15.17% | View Filing |